These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27050806)

  • 1. Modeling of in-use stability for tablets and powders in bottles.
    Waterman KC; Chen L; Waterman P; MacDonald BC; Monahan AP; Scrivens G
    Drug Dev Ind Pharm; 2016 Oct; 42(10):1571-8. PubMed ID: 27050806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanistic model for the prediction of in-use moisture uptake by packaged dosage forms.
    Remmelgas J; Simonutti AL; Ronkvist A; Gradinarsky L; Löfgren A
    Int J Pharm; 2013 Jan; 441(1-2):316-22. PubMed ID: 23194882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaceutical solid-state kinetic stability investigation by using moisture-modified Arrhenius equation and JMP statistical software.
    Fu M; Perlman M; Lu Q; Varga C
    J Pharm Biomed Anal; 2015 Mar; 107():370-7. PubMed ID: 25656488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of drug physical form during granulation, tabletting and storage.
    Williams AC; Cooper VB; Thomas L; Griffith LJ; Petts CR; Booth SW
    Int J Pharm; 2004 May; 275(1-2):29-39. PubMed ID: 15081136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling moisture change of packaged dry tablet dosage forms under consumer use condition.
    An DS; Lee DS
    Drug Dev Ind Pharm; 2024 Jul; 50(7):639-645. PubMed ID: 39030666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole.
    Brits M; Liebenberg W; de Villiers MM
    J Pharm Sci; 2010 Mar; 99(3):1138-51. PubMed ID: 19691117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated shelf life modeling of appearance change in drug products using ASAP
    Flavier K; McLellan J; Botoy T; Waterman KC
    Pharm Dev Technol; 2022 Jul; 27(6):740-748. PubMed ID: 35950863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Package selection for moisture protection for solid, oral drug products.
    Waterman KC; MacDonald BC
    J Pharm Sci; 2010 Nov; 99(11):4437-52. PubMed ID: 20845442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of sorption--desorption moisture transfer modeling to the study of chemical stability of a moisture sensitive drug product in different packaging configurations.
    Badawy SI; Gawronski AJ; Alvarez FJ
    Int J Pharm; 2001 Jul; 223(1-2):1-13. PubMed ID: 11451627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of the Accelerated Stability Assessment Program (ASAP) to quality by design (QbD) for drug product stability.
    Waterman KC
    AAPS PharmSciTech; 2011 Sep; 12(3):932-7. PubMed ID: 21748541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of moisture content, temperature and exposure time on the physical stability of chitosan powder and tablets.
    Viljoen JM; Steenekamp JH; Marais AF; Kotzé AF
    Drug Dev Ind Pharm; 2014 Jun; 40(6):730-42. PubMed ID: 23596972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of water vapor transmission rate (WVTR) of HDPE bottles for pharmaceutical products.
    Chen Y; Li Y
    Int J Pharm; 2008 Jun; 358(1-2):137-43. PubMed ID: 18448285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of packaging and storage on the stability of carbamazepine tablets.
    al-Zein H; Riad LE; Abd-Elbary A
    Drug Dev Ind Pharm; 1999 Feb; 25(2):223-7. PubMed ID: 10065356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the Long-Term Dissolution Performance of an Immediate-Release Tablet Using Accelerated Stability Studies.
    Scrivens G
    J Pharm Sci; 2019 Jan; 108(1):506-515. PubMed ID: 30595168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of degradation of imidapril hydrochloride in finished dosage formulations.
    Stanisz B; Regulska K
    Acta Pol Pharm; 2013; 70(4):737-42. PubMed ID: 23923397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality by design development of brivanib alaninate tablets: degradant and moisture control strategy.
    Badawy SI; Lin J; Gokhale M; Desai S; Nesarikar VV; LaMarche KR; Subramanian GA; Narang AS
    Int J Pharm; 2014 Jul; 469(1):111-20. PubMed ID: 24780101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilazapril stability in the presence of hydrochlorothiazide in model mixtures and fixed dose combination.
    Paszun SK; Stanisz BJ; Gradowska A
    Acta Pol Pharm; 2013; 70(6):1079-85. PubMed ID: 24383331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of sodium valproate tablets repackaged into dose administration aids.
    Llewelyn VK; Mangan MF; Glass BD
    J Pharm Pharmacol; 2010 Jul; 62(7):838-43. PubMed ID: 20636871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms.
    Waterman KC; Carella AJ; Gumkowski MJ; Lukulay P; MacDonald BC; Roy MC; Shamblin SL
    Pharm Res; 2007 Apr; 24(4):780-90. PubMed ID: 17372701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of near infrared and microwave resonance sensors for at-line moisture determination in powders and tablets.
    Corredor CC; Bu D; Both D
    Anal Chim Acta; 2011 Jun; 696(1-2):84-93. PubMed ID: 21621036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.